NCT04438304 2025-02-12A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)Clarity Pharmaceuticals LtdPhase 2 Completed45 enrolled
NCT04440956 2020-06-22An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine TumoursClarity Pharmaceuticals LtdPhase EARLY_PHASE1 Completed10 enrolled